Zylox-Tonbridge

Zylox-Tonbridge Medical Technology Co., Ltd. (referred to as "Zylox-Tonbridge," stock code: 2190.HK) is a company focused on the innovation, research and development, manufacturing, and sales services of medical devices in the vascular intervention field. Established in 2012, the company's headquarters is located in Hangzhou Future Sci-Tech City, with offices and R&D centers in Zhuhai, Beijing, Shanghai, and other locations. Zylox-Tonbridge has consistently adhered to the strategy of "innovation-driven and platform empowerment," committed to providing patients with high-quality and affordable medical devices and solutions, enabling everyone to enjoy a high-quality life brought by advanced medical technologies. Since its founding, Zylox-Tonbridge has launched a series of high-end medical devices with independent intellectual property rights in the peripheral and neurovascular intervention fields, filling gaps both domestically and internationally. Looking ahead, Zylox-Tonbridge will continue to create comprehensive solutions for high-quality medical devices through innovative concepts and solid craftsmanship, becoming a leader in the vascular intervention field, helping patients worldwide access better and more accessible medical devices and services, and improving the quality of life.